Five Subtypes of Liver Disease MASLD

Researchers at Mayo Clinic and Virginia Tech have identified five biologically distinct subtypes of metabolic dysfunction-associated steatotic liver disease, a condition affecting nearly 30 percent of adults worldwide. By combining genetic sequencing and detailed clinical information from over 4,600 patients using advanced computational modeling, the team uncovered that inherited genetic factors drive specific forms of the disease with higher risks of advanced liver damage, independent of typical metabolic risk factors like obesity and diabetes. The study emphasizes shifting from a broad diagnosis of fatty liver disease to a precision-medicine framework that maps complex biological pathways. Co-senior authors Shulan Tian and Eric Klee highlight that these genomic insights allow researchers to anticipate disease progression and match treatments to the precise biological drivers for individual patients, moving beyond generalized care approaches. The research utilized Mayo Clinic's Research Data Atlas and Tapestry Study data, which integrates exome data from over 100,000 participants with electronic health records. This large-scale infrastructure enabled scientists to uncover hidden clinical patterns and establish that specific disease subtypes are also linked to extra-hepatic conditions such as depression, sleep apnea, and migraines. These findings pave the way for refined clinical screening, earlier risk identification, and targeted interventions in broader populations. Future steps include testing how these newly defined subtypes respond to emerging therapies, including GLP-1 receptor agonists, ultimately improving individualized patient outcomes across multiple organ systems.